Metabolic Dysfunction-Associated Steatotic Liver Disease Linked to Risk for Sudden Hearing Loss
FRIDAY, June 20, 2025 -- Among older adults, metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with increased risk for sudden sensorineural hearing loss (SSNHL), according to a study published in the June issue of Laryngoscope: Investigative Otolaryngology.
Eun Seok Kang, M.D., from the Korea University College of Medicine in Seoul, and colleagues conducted a population-based cohort study using the Korean National Health Insurance Service-Senior cohort involving 189,623 participants aged 65 years or older who were categorized as non-SLD or MASLD. The risk for SSNHL and Meniere disease was examined.
The researchers found that compared with the non-SLD group, participants with MASLD had higher metabolic dysfunction markers, including elevated body mass index, waist circumference, and blood pressure. There were 3,803 SSNHL events in the MASLD group during nine years of follow-up, with an incidence rate of 2.44 per 1,000 person-years. MASLD was associated with a significantly increased risk for SSNHL after inverse probability of treatment weighting (adjusted hazard ratio, 1.05; subdistribution hazard ratio, 1.06).
"This finding serves as an important indicator that reflects the impact of MASLD on disease progression from a prognostic perspective, rather than merely examining the occurrence of the disease itself," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
WEDNESDAY, Oct. 1, 2025 -- People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems compared with patients treated...
Patients With Extreme Obesity Face Limitations to Accessing Specialty Care
TUESDAY, Sept. 30, 2025 -- Patients weighing more than 450 lb face considerable limitations when attempting to access specialty care, according to a research letter published...
GLP-1 Receptor Agonists Tied to Reduced Mortality in Patients With Psoriasis
TUESDAY, Sept. 30, 2025 -- Patients with psoriasis treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have better long-term outcomes compared with those taking...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.